Home
About
Pricing
Log In
Back
LDX
Asset Logo

Lumos Diagnostics Holdings Limited

๐Ÿ‡ฆ๐Ÿ‡บ ASX

๐Ÿฉบ HEALTH CARE

Compare
Add to watchlist
๐Ÿ‘‘ Overview

๐Ÿ“ˆ Performance

๐Ÿ’ต Cost

๐Ÿค“ Advanced

๐Ÿ‘จโ€๐Ÿ‘ฉโ€๐Ÿ‘งโ€๐Ÿ‘ฆ Community

๐Ÿ“ˆ

-22.62%
Annual Growth

4 years average annual capital growth

๐Ÿ’ต

$ 500
Minimum Order

Due to regulatory requirements

๐ŸŒ

9
Pearlers Invested

Since January 2020

๐Ÿ‘‘ Overview

Key information
๐Ÿ”Ž Fund Overview

Lumos Diagnostics Holdings Ltd. engages in the development and manufacture of point-of-care diagnostics solutions to help healthcare professionals more accurately diagnose and manage medical conditions. The company is headquartered in South Melbourne, Victoria. The company went IPO on 2021-07-05. The firm offers customized assay development and manufacturing services for POC tests and digital reader platforms. The company also directly develops, manufactures, and commercializes, Lumos-branded POC tests that target infectious and inflammatory diseases. Its Products offering is based on developing and commercializing its own suite of POC diagnostic products which are primarily focused on the diagnosis and management of infectious diseases. These include FebriDx, a POC test for detecting and differentiating viral and bacterial respiratory infections and ViraDx, a three-in-one POC test for influenza A, influenza B and COVID-19. Its services include assay development, reader development, cloud and data, and manufacturing. The company manages the full development program for POC assays.

๐Ÿ“ˆ Performance

Price History

-92.57%

1M

1Y

All Time

Graph

Table

Unsure how much or often to invest?
๐Ÿ—“๏ธ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out โ†’
๐Ÿ’ต Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out โ†’
โฑ๏ธ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out โ†’

๐Ÿ’ต Costs

๐Ÿ’ต

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

๐Ÿ’ผ

N/A
Management Fee

Included in unit price, not charged by Pearler

๐Ÿ’ธ

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
๐Ÿ’ธ Net fee calculator

๐Ÿค“ Advanced information

Technical Info

๐Ÿ’ฐ Price*

$0.09

*Price may be up to 24 hours old

๐Ÿ‘ฉโ€๐Ÿ‘ฉโ€๐Ÿ‘ฆ Community Insights

How our community is investing

๐ŸŒ Pearlers invested in LDX

9

๐Ÿ“Š Total Capital Earnings

$56K

๐Ÿ”ƒ Average investment frequency

27 weeks

๐Ÿ’ต Average investment amount

$2,952

โฐ Last time a customer invested in LDX

4 days
LDX investor breakdown
๐Ÿ’ต Income of investors

More than 200k

150k - 200k

18%

100k - 150k

50k - 100k

55%

Less than 50k

27%
๐Ÿ‘ถ Age of investors

18 - 25

26 - 34

35 - 90

89%
๐Ÿ™‹ Legal gender of investors

Female

44%

Male

56%

Pearlers who invest in LDX also invest in...

Pilbara Minerals Limited

PLS

Pilbara Minerals Ltd. engages in the provision of exploration and evaluation of mineral properties. The company is headquartered in Perth, Western Australia and currently employs 917 full-time employees. The company went IPO on 2007-09-19. The firm owns 100% of an independent hard-rock lithium operation, the Pilgangoora operation in Australia, and the Colina Project in Brazil. Its Pilgangoora operation is located 140 kilometers (kms) from Port Hedland in Western Australiaโ€™s resource rich Pilbara region on Nyamal and Kariyarra Country. Spodumene concentrate from its Pilgangoora operation is shipped from Port Hedland, the bulk export port, to lithium chemical converters primarily in China. The firm's Colina project is located 10 kms from the town of Salinas in the world class mining jurisdiction of Minas Gerais, Brazil. The firm is also integrated into the lithium value chain through its joint venture with POSCO in South Korea, which manufactures battery-grade lithium hydroxide.

๐Ÿ™Œ Performance (5Yr p.a)

77.61%

๐Ÿ“Š Share price

$1.71 AUD

๐Ÿ•Š๏ธ SOCIALLY AWARE

โ›๏ธ MINING

Find Out More

Telix Pharmaceuticals Limited.engages in the development and commercialization of several clinical-stage oncology assets. The company is headquartered in Melbourne, Victoria. The company went IPO on 2017-11-15. The company is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.

๐Ÿ™Œ Performance (5Yr p.a)

276.48%

๐Ÿ“Š Share price

$18.53 AUD

๐Ÿงฌ BIOTECHNOLOGY

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.

๐Ÿ™Œ Performance (5Yr p.a)

17.09%

๐Ÿ“Š Share price

$145.69 AUD

๐ŸŒ GLOBAL

๐Ÿค– TECHNOLOGY

๐Ÿ“ˆ HIGH PRICE GROWTH

โ›ณ๏ธ DIVERSIFIED

NDQ.AX was created on 2015-05-26 by BetaShares. The fund's investment portfolio concentrates primarily on large cap equity. The fund aims to track the performance of the NASDAQ-100 Index (before fees and expenses). The NASDAQ-100 comprises 100 of the largest non-financial companies listed on the NASDAQ market, and includes many companies that are at the forefront of the new economy.

๐Ÿ™Œ Performance (5Yr p.a)

21.40%

๐Ÿ“Š Share price

$53.01 AUD

๐Ÿ“ˆ HIGH PRICE GROWTH

๐Ÿค– TECHNOLOGY

๐Ÿ‡บ๐Ÿ‡ธ UNITED STATES

VAS.AX was created on 2009-05-04 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. The ETF currently has 21391.62m in AUM and 303 holdings. Vanguard Australian Shares Index ETF seeks to track the return of the S&P/ASX 300 Index before taking into account fees, expenses and tax.

๐Ÿ™Œ Performance (5Yr p.a)

8.51%

๐Ÿ“Š Share price

$108.61 AUD

๐Ÿ’ธ FINANCIALS

๐Ÿ‡ฆ๐Ÿ‡บ AUSTRALIA

โ›ณ๏ธ DIVERSIFIED

๐Ÿงฑ MATERIALS

๐Ÿ“ˆ HIGH PRICE GROWTH

Want more shares? Try these...

LDXAJ

Compare
Add to watchlist